Company Filing History:
Years Active: 2020-2022
Title: Yeong Su Jang: Innovator in Cancer Treatment
Introduction
Yeong Su Jang is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of cancer treatment through his innovative pharmaceutical compositions. With a total of 2 patents, Jang is dedicated to advancing medical science and improving patient outcomes.
Latest Patents
Jang's latest patents focus on pharmaceutical compositions for treating cancer that utilize lactate metal salts. These compositions are designed to inhibit the proliferation, invasion, and metastasis of cancer cells by disrupting their metabolic processes. The active ingredient, a metal lactate salt, can be dissociated in cancer cells into lactate, which effectively targets the main energy production pathways of cancer. His inventions also include methods for treating cancer and inhibiting cancer metastasis, both of which involve administering the lactate metal salt. Notably, these compositions have shown the potential to inhibit the expression of factors that induce resistance to radiation exposure, all while maintaining a favorable safety profile.
Career Highlights
Yeong Su Jang is currently associated with Metimedi Pharmaceuticals Co., Ltd., where he continues to develop innovative solutions for cancer treatment. His work is characterized by a commitment to research and development in the pharmaceutical industry, particularly in the area of oncology.
Collaborations
Jang collaborates with notable colleagues, including Hwan Mook Kim and Keun Yeong Jeong, to further enhance the impact of his research and inventions. Their combined expertise contributes to the advancement of cancer therapies.
Conclusion
Yeong Su Jang is a dedicated inventor whose work in cancer treatment through innovative pharmaceutical compositions is paving the way for more effective therapies. His contributions are vital in the ongoing fight against cancer, and his patents reflect a commitment to improving patient care.